Document is current
Any future updates will be listed below
-
Authors
Martelli, Gabriele
Barretta, Francesco
Muzi, Carlo
Listorti, Chiara
Pilotta, Federica
Maugeri, Ilaria
Osio, Chiara
Bonfili, Deborah
Vernieri, Claudio
Bianchi, Giulia
Pruneri, Giancarlo
Folli, Secondo
Scaperrotta, Gianfranco
Baili, Paolo
Miceli, Rosalba
Ferraris, Cristina
-
Funding
Funding for this research was provided by:
Ministero della Salute (“5 per 1000” funds for healthcare research)
- License Information
-
More Information
Article History
Received: 15 August 2025
Accepted: 22 October 2025
First Online: 18 November 2025
Disclosure
: Dr. Vernieri reports being a member of advisory boards for Novartis, Lilly, Pfizer, Menarini Stemline, and Daiichi Sankyo. He has received honoraria as speaker for Lilly, Novartis, Pfizer, Astra Zeneca, Menarini Stemline MSD, Istituto Gentili, and Accademia Nazionale di Medicina. Dr. Pruneri reports receiving honoraria from Lilly, Astra Zeneca, Menarini, Roche, and Illumina, and is on the Advisory Board of ADS Biotech.
